@MATES4Kids strives for equitable access to essential medicines, equipment, vaccines and technologies of assured quality, safety, efficacy and cost-effectiveness, with scientifically sound and cost-effective use, to support the timely diagnosis and optimal management of CAH.
Medicines and equipment must be available:
Access can be supported by: national policies, standards, guidelines and regulations to support policy; transparency of information on prices, status of international trade agreements and negotiatioin of prices;
in-country manfuacture of quality products; robust procurement, supply, storage and distribution proceses; rational use of medicines; guidelines and strategies to assure adherence, reduce resistance, maximise patient safety and promote training.
Medicines and equipment must be available:
- Within a functioning health system
- At all times
- In sufficient quantity
- With assured quality
- At prices that people can afford
Access can be supported by: national policies, standards, guidelines and regulations to support policy; transparency of information on prices, status of international trade agreements and negotiatioin of prices;
in-country manfuacture of quality products; robust procurement, supply, storage and distribution proceses; rational use of medicines; guidelines and strategies to assure adherence, reduce resistance, maximise patient safety and promote training.
|
The WHO Prequalification Program
|
2023 WHO Essential Medicines List for Children - contains hydrocortisone (tablets / injection) and fludrocortisone (tablets).
|
The WHO Essential Diagnostics List
|